Background illustration for clinical trials search

Paid Clinical Trials Rockville

Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Bethesda MD, Washington D.C. DC, Falls Church VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Evaluation of Children With Endocrine and Metabolic-Related Conditions

for
Adrenal Insufficiency, Growth Disorder, Endocrine Diseases,
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 70+

Code: NCT02769975

Recruiting

Safety of HRX215 in Patients After Minor and Major Liver Resection

for
Liver Resection, Colorectal Carcinoma Liver Metastases
Location: Baltimore MD, Durham NC, Cleveland OH, Rochester MN
Sponsor: HepaRegeniX GmbH

Sex: All

Age: 18 - 70+

Code: NCT06638502

Phase1, Phase2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Washington D.C. DC, Fairfax VA, Columbia MD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Towson MD, Hanover PA, Martinsburg WV, Gettysburg PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

Trifecta-Kidney cfDNA-MMDx Study

for
Kidney Transplant Rejection
Location: Baltimore MD, Richmond VA, Cleveland OH, Detroit MI,
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT04239703

Recruiting

Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

for
Advanced Non Small Cell Lung Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05777603

Phase1, Recruiting

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: Baltimore MD, Marietta GA, Richmond VA, New York NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT06920043

Phase2, Recruiting

Systemic Hypothermia in Acute Cervical Spinal Cord Injury

for
Spinal Cord Injury, Acute
Location: Baltimore MD, Philadelphia PA, Columbia SC, Miami FL,
Sponsor: University of Miami

Sex: All

Age: 18 - 70

Code: NCT02991690

Recruiting

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

for
Recurrent Thyroid Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT04892303

Phase1, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Baltimore MD, Charlottesville VA, Philadelphia PA,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Fairfax VA, Baltimore MD, Richmond VA,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Bethesda MD, Washington D.C. DC, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: CorMedix Therapeutics

Sex: All

Age: 12+

Code: NCT06822426

Phase3, Recruiting

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

for
Mood Disorder
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 7 - 70+

Code: NCT00025935

Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for
Smoldering Plasma Cell Myeloma
Location: Baltimore MD, Hershey PA, Charlottesville VA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase3, Recruiting

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

for
Peripheral Nerve Injuries
Location: Baltimore MD, Philadelphia PA, New York NY, Columbus OH,
Sponsor: Auxilium Biotechnologies

Sex: All

Age: 18 - 70+

Code: NCT06529835

Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Baltimore MD, Westminster MD, Gettysburg PA, York PA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase3, Recruiting

Natural History Study of Patients With Excess Androgen

for
Congenital Adrenal Hyperplasia (CAH),
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 70+

Code: NCT00250159

Recruiting